Alnylam Pharmaceuticals, Inc. (ALNY) vs Neurocrine Biosciences, Inc. (NBIX)
Detailed comparison between Alnylam Pharmaceuticals, Inc., Neurocrine Biosciences, Inc..Total Return (%)
Alnylam Pharmaceuticals, Inc. (ALNY)Neurocrine Biosciences, Inc. (NBIX)
Which stock do you think will perform better?
Alnylam Pharmaceuticals, Inc.
ALNY
Neurocrine Biosciences, Inc.
NBIX
| Metric | Alnylam Pharmaceuticals, Inc. (ALNY) | Neurocrine Biosciences, Inc. (NBIX) |
|---|---|---|
| Current Price | $266.86 | $116.87 |
| Change | -3.33 (-1.23%) | -3.56 (-2.96%) |
| Market Cap | $34.80B | $11.57B |
| Trailing P/E | 0.00 | 39.62 |
| Forward P/E | -218.74 | 18.82 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $304.39 | $157.98 |
| 52-Week Low | $144.73 | $84.23 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-2.11 | $2.95 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| ALNY | 15.56% | 6.31% | 81.04% | 91.60% | 122.68% | 130.31% |
| NBIX | 21.54% | -18.02% | -17.70% | 0.32% | 180.74% | 178.66% |